(Q72280929)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

L B Anthony

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

T J Boeve

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K R Hande

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

125-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00689196

25 October 2019

exact match

0 references

cites work

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

12 December 2020

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

1 reference

12 December 2020

Simplified phenotyping with dextromethorphan by thin-layer chromatography: application to clinical laboratory screening for deficiencies in oxidative drug metabolism

1 reference

12 December 2020

Role of genetics and drug metabolism in human cancer risk

1 reference

12 December 2020

Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine

1 reference

12 December 2020

Clinical consequences of polymorphic drug oxidation

1 reference

12 December 2020

Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism

1 reference

12 December 2020

Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype

1 reference

12 December 2020

Clinical Implications of the Competitive Inhibition of the Debrisoquin-Metabolizing Isozyme by Quinidine

1 reference

12 December 2020

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

12 December 2020

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

1 reference

12 December 2020

Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

1 reference

12 December 2020

Determination of dextromethorphan metabolizer phenotype in healthy volunteers

1 reference

12 December 2020

Differential inhibition of individual human liver cytochromes P-450 by cimetidine

1 reference

12 December 2020

Polymorphic oxidation of debrisoquine in women with breast cancer

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Genetically determined polymorphisms in drug oxidation

1 reference

12 December 2020

Polymorphic Oxidation of Debrisoquine in Bladder Cancer

1 reference

12 December 2020

Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism

1 reference

12 December 2020

Relevance of genetic polymorphism in drug metabolism in the development of new drugs

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans

1 reference

12 December 2020

Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans

1 reference

12 December 2020

The metabolism of [14C]-debrisoquine in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7767948%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference